Sat, Jul 26, 2014, 5:47 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Amgen, Inc. (AMGN) Message Board

fredthecpa 5 posts  |  Last Activity: Jun 27, 2014 7:47 AM Member since: Feb 5, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Pfizer Job Listing-cpb38

    by better3l Jun 26, 2014 2:47 PM
    fredthecpa fredthecpa Jun 27, 2014 7:47 AM Flag

    I believe that this is oversimplification on your part. I do believe that if you have this question, you should address it with management during their quarterly conferences and disclose what they have to say. Incidentally, this is the second time that you made the same assertion almost with the same words. Any reason for the duplication? I am still bullish on this Company. It is interesting to note the number of personnel that the Corporation is looking for to fill positions including a senior accountant. A Company in trouble would not be doing this.

  • fredthecpa fredthecpa Jun 23, 2014 6:58 AM Flag

    I did not mean to imply either of the two things you mentioned nor do I wish anything bad to happen to Mr Ichan physically or any other way to him or his family. What I did state is that anytime that Mr. Ichan's name is associated with something even if it is a contribution to a medical facility in his name, it would not be a stretch for him to hear about the success of tumorgraft technology since I am certain that he is kept abreast of things in an institution for which he made such a significant contribution especially since the technology comes from David Sidransky who is a man that he is familiar with through their connection with Imclone. I am also not saying that anything will happen over the short term, but I am saying it could have a long-term effect if Mr.. Icahn is kept abreast of these developments. I also said that now would be a good time for CSBR to show what the tumorgraft technology could and its superiority in comparison to the other technologies (methods) that the research by the hospital is testing.

  • fredthecpa fredthecpa Jun 18, 2014 8:42 AM Flag

    I believe that the announcement made yesterday regarding the participation o the Icahn School of medicine at Mount Sinai Hospital and CSBR initiating a study involving tumorgrafts ability to predict treatment in patients with breast cancer is very significant. Mr. Icahn has served on the Board of Directors with David Sidranski at Imclone. I understand they are also friends. While Mr. Icahn is not now getting involved with CSBR financially, nevertheless the School of Medicine at Mount Sinai Hospital named after Mr. Icahn is.getting involved. This opportunity is very important to CSBR since it gives them a chance to show Mr. Icahn how good tumorgraft technology really is. If the tumorgraft platform slike it is supposed to it would give CSBR a tremendous boost. This would be particularly true if, G-D for bid, a member of Mr. Icahn's extended family developed breast cancer and through tumprgraft technology CSBR was able to reduce the cancer or even eliminate the cancer, it would be a tremendous boost to the credibility of the tumorgraft platform and, as important, it would get the attention up close and personal of Mr. Icahn.

  • Reply to

    Current Pfizer job listing

    by cpb38 May 3, 2014 6:02 PM
    fredthecpa fredthecpa May 28, 2014 7:11 AM Flag

    I was stating that from the information that I have reviewed apparently xenograft technology is inferior. I have a problem with why they would be opening up an inhouse dept if they already have an agreement with CSBR unless they want to cover all of their bases. Actually, a good idea would be for you to ask the CSBR C.E.O. what he knows about this at the next conference that he holds after the issuance of the yearly financial statements which will probably take place in June.

  • Reply to

    Current Pfizer job listing

    by cpb38 May 3, 2014 6:02 PM
    fredthecpa fredthecpa May 27, 2014 12:02 PM Flag

    Pfizer may be using Xenograft technology which is inferior to the technology used by CSBR. I am not certain as to whether there is any competition here since I believe that Pfizer is one of CSBR's customers.

AMGN
122.84+0.58(+0.47%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.